Cargando…

The effectiveness of three different 7 + 3 induction regimes in China: A retrospective analysis in adult patients with acute myeloid leukemia

OBJECTIVES: In China, for economic reasons, induction regimes for acute myeloid leukemia (AML) often involve domestically produced idarubicin (IDA) rather than imported IDA. Our objective was to compare the effectiveness of induction regimens in combination with cytarabine; involving imported or dom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Peng, Zhou, Boliang, Yao, Haiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Professional Medical Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794117/ https://www.ncbi.nlm.nih.gov/pubmed/33437245 http://dx.doi.org/10.12669/pjms.37.1.2563

Ejemplares similares

Effect of carboplatin injection on Bcl-2 protein expression and apoptosis induction in Raji cells
por: Lin, Peng, et al.
Publicado: (2020)

Age and remission induction therapy for acute myeloid leukemia: An analysis of data from the Korean acute myeloid leukemia registry
por: Yoo, Kwai Han, et al.
Publicado: (2021)

Frequency of complete remission after standard 3+7 induction therapy in patients with acute myeloid leukemia
por: Shireen, Iram, et al.
Publicado: (2022)

Comparison of the effects of early intensified induction chemotherapy and standard 3+7 chemotherapy in adult patients with acute myeloid leukemia
por: Yoon, Jae-Ho, et al.
Publicado: (2017)

The “7+3” regimen in acute myeloid leukemia
por: Rowe, Jacob M.
Publicado: (2022)

Papular eruption after induction chemotherapy for acute myeloid leukemia
por: Novice, Taylor, et al.
Publicado: (2020)

Post-Induction Treatment for Acute Myeloid Leukemia: Something Change?
por: Jaramillo, Sonia, et al.
Publicado: (2021)

Venetoclax plus cyclophosphamide and cytarabine as induction regimen for adult acute myeloid leukemia
por: Zhang, Baohang, et al.
Publicado: (2023)

Novel Translocation in Acute Myeloid Leukemia: Case Report and Review of Risk-Stratification and Induction Chemotherapy in Patients With Acute Myeloid Leukemia
por: Jeha, George M., et al.
Publicado: (2020)

Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review
por: Abuelgasim, Khadega A., et al.
Publicado: (2020)

594. Micafungin Prophylaxis in Acute Myeloid Leukemia Adult Patients Undergoing Induction Chemotherapy
por: Ross, Justine Abella, et al.
Publicado: (2021)

Combination of cyclophosphamide and cytarabine as induction regimen for newly diagnosed adult acute myeloid leukemia
por: Liu, Qingguo, et al.
Publicado: (2020)

Fatal Idiopathic Hyperammonemia after Induction Chemotherapy for Acute Myeloid Leukemia
por: Angelo, Christophe, et al.
Publicado: (2020)

Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?
por: McCurdy, Shannon R., et al.
Publicado: (2021)

Neutropenic Enterocolitis Complicating Induction Chemotherapy in an Acute Myeloid Leukemia Patient
por: Groudan, Kevin, et al.
Publicado: (2021)

Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2022)

Chemoresponse of de novo Acute Myeloid Leukemia to “7+3” Induction can Be Predicted by c-Myc-facilitated Cytogenetics
por: Hsiao, Tzu-Hung, et al.
Publicado: (2021)

A Phase I Trial of Sirolimus with “7&3” Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
por: Palmisiano, Neil, et al.
Publicado: (2023)

Predictive value of integrin α7 for acute myeloid leukemia risk and its correlation with prognosis in acute myeloid leukemia patients
por: Zeng, Mingyue, et al.
Publicado: (2019)

FoxO1-Dependent Induction of Acute Myeloid Leukemia by Osteoblasts in Mice
por: Kode, Aruna, et al.
Publicado: (2015)

Low-intensity induction in acute myeloid leukemia. Always in the patients' best interest?
por: Atallah, Ehab
Publicado: (2022)

Chasing quality remission in acute myeloid leukemia: intensity of induction and residual disease
por: Ofran, Yishai
Publicado: (2023)

Expression and prognosis of the B7 family in acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2021)

Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re‐induction chemotherapy
por: Ruan, Min, et al.
Publicado: (2021)

Correction: Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial
por: Radhakrishnan, Venkatraman, et al.
Publicado: (2022)

Association of leukocyte nadir with complete remission in Indonesian acute myeloid leukemia patients undergoing 7+3 remission induction chemotherapy
por: Hadisantoso, Dwi Wahyunianto, et al.
Publicado: (2022)

Acute myeloid leukemia in the older adults
por: Almeida, Antonio M., et al.
Publicado: (2016)

Treatment of acute myeloid leukaemia with a triple cytotoxic regime: DAT.
por: Rees, J. K., et al.
Publicado: (1977)

In-silico comparison of two induction regimens (7 + 3 vs 7 + 3 plus additional bone marrow evaluation) in acute myeloid leukemia treatment
por: Banck, Jan Christoph, et al.
Publicado: (2019)

Epidemiology and risk factors for invasive fungal infections during induction chemotherapy for newly diagnosed acute myeloid leukemia: A retrospective cohort study
por: Lien, Ming-Yu, et al.
Publicado: (2018)

Induction of Differentiation of Mouse Myeloid Leukemia M1 Cells by Serum of Patients with Chronic Myeloid Leukemia
por: Okabe‐Kado, Junko, et al.
Publicado: (1988)

Acute Myeloid Leukemia
Publicado: (2019)

Acute myeloid leukemia
por: Haferlach, Torsten
Publicado: (2019)

Acute myeloid leukemia
por: Ossenkoppele, Gert
Publicado: (2018)

Acute Myeloid Leukemia with Occult Systemic Mastocytosis or Atypical Mast Cells Post-induction
por: Khan, Salahuddin, et al.
Publicado: (2018)

Low-intensity regimens versus standard-intensity induction strategies in acute myeloid leukemia
por: Vey, Norbert
Publicado: (2020)

Spontaneous splenic rupture during induction therapy in acute myeloid leukemia: An unusual case.
por: Tavarozzi, Rita, et al.
Publicado: (2021)

Advancing the standard: venetoclax combined with intensive induction and consolidation therapy for acute myeloid leukemia
por: Lachowiez, Curtis A., et al.
Publicado: (2022)

Benefit of intermediate-dose cytarabine-containing induction in molecular subgroups of acute myeloid leukemia
por: Wei, Hui, et al.
Publicado: (2020)

Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
por: Cherry, Evan M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7b6v4be7qrd8k2uk1v23h3q48a